1Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood, 2000, 95 : 2637-2644.
2Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res, 1999,59:728-733.
3Fiedler W, Graeven U, Ergun S, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.Blood, 1997,89 : 1870-1875.
4Fusetti L, Pruneri G, Gobbi A, et al. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production. Cancer Res,2000,60: 2527-2534.
同被引文献5
1张之南.血液病治疗及疗效标准(第2版)[M].北京:科学出版社,1998.349-358.
2Morra E.The biological markers of non-Hodgkin's lymphomas:their role in diagnosis,prognostic assessment and therapeutic strategy.Int J Biol Markers.1999,14:149-153.
3Scott P A,Gleadle J M,Bicknell R,et al.Role of the hypoxia sensing system,acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines.Int J Cancer,1998,75:706-712.
4Aguayo A,Kantarjian H,Manshouri T,et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.Blood,2000,96:2240-2245.
